It has previously been shown that CTC5 inhibits HIV-1 entry in CCR5 transfected CD4+ cell lines and CD4+ T cells [37, 69], and we now show that this antibody reduced infection of MDMs (Fig. 6). This evidence concerns the gene CCR5 and infection.